E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/6/2006 in the Prospect News Biotech Daily.

Jefferies maintains Kendle at hold

Kendle International Inc. was kept at a hold rating by Jefferies & Co., Inc. analyst David Windley. Jefferies lowered its price target to $336 from $40. The maintained hold rating is due in part on the risk of successfully integrating an underperforming phase 2-4 business. Shares of the Cincinnati, Ohio-based clinical development services company were up $1.71, or 5.10%, at $35.24 on volume of 409,763 shares versus the three-month running average of 179,578 shares. (Nasdaq: KNDL)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.